Evaluation of some thiophene-based sulfonamides as potent inhibitors of carbonic anhydrase I and II isoenzymes isolated from human erythrocytes by kinetic and molecular modelling studies

Background Thiophene(s) are an important group in therapeutic applications, and sulfonamides are the most important class of carbonic anhydrase (CA) inhibitors. In this study, inhibition effects of some thiophene-based sulfonamides on human erythrocytes carbonic anhydrase I and II isoenzymes (hCA-I...

Full description

Saved in:
Bibliographic Details
Published inPharmacological reports Vol. 72; no. 6; pp. 1738 - 1748
Main Authors Alım, Zuhal, Köksal, Zeynep, Karaman, Muhammet
Format Journal Article
LanguageEnglish
Published Cham Springer International Publishing 01.12.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background Thiophene(s) are an important group in therapeutic applications, and sulfonamides are the most important class of carbonic anhydrase (CA) inhibitors. In this study, inhibition effects of some thiophene-based sulfonamides on human erythrocytes carbonic anhydrase I and II isoenzymes (hCA-I and hCA-II) were investigated. Thiophene-based sulfonamides used in this study showed potent inhibition effect on both isoenzymes at very small concentrations. Materials and methods We report on the purification of the carbonic anhydrase I and II isoenzymes (hCA-I and hCA-II) using affinity chromatography method. The inhibition effect of the thiophene-based sulfonamides was determined by IC 50 and K i parameters. A molecular docking study was performed for each molecule. Results Thiophene-based sulfonamides showed IC 50 values of in the range of 69 nM to 70 µM against hCA-I, 23.4 nM to 1.405 µM against hCA-II. K i values were in the range of 66.49 ± 17.15 nM to 234.99 ± 15.44 µM against hCA-I, 74.88 ± 20.65 nM to 38.04 ± 12.97 µM against hCA-II. Thiophene-based sulfonamides studied in this research showed noncompetitive inhibitory properties on both isoenzymes. To elucidate the mechanism of inhibition, a molecular docking study was performed for molecules 1 and 4 exhibiting a strong inhibitory effect on hCA-I and hCA-II. The compounds inhibit the enzymes by interacting out of catalytic active site. The sulfonamide and thiophene moiety played a significant role in the inhibition of the enzymes. Conclusion We hope that this study will contribute to the design of novel thiophene-based sulfonamide derived therapeutic agents that may be carbonic anhydrase inhibitors in inhibitor design studies.
AbstractList Background Thiophene(s) are an important group in therapeutic applications, and sulfonamides are the most important class of carbonic anhydrase (CA) inhibitors. In this study, inhibition effects of some thiophene-based sulfonamides on human erythrocytes carbonic anhydrase I and II isoenzymes (hCA-I and hCA-II) were investigated. Thiophene-based sulfonamides used in this study showed potent inhibition effect on both isoenzymes at very small concentrations. Materials and methods We report on the purification of the carbonic anhydrase I and II isoenzymes (hCA-I and hCA-II) using affinity chromatography method. The inhibition effect of the thiophene-based sulfonamides was determined by IC 50 and K i parameters. A molecular docking study was performed for each molecule. Results Thiophene-based sulfonamides showed IC 50 values of in the range of 69 nM to 70 µM against hCA-I, 23.4 nM to 1.405 µM against hCA-II. K i values were in the range of 66.49 ± 17.15 nM to 234.99 ± 15.44 µM against hCA-I, 74.88 ± 20.65 nM to 38.04 ± 12.97 µM against hCA-II. Thiophene-based sulfonamides studied in this research showed noncompetitive inhibitory properties on both isoenzymes. To elucidate the mechanism of inhibition, a molecular docking study was performed for molecules 1 and 4 exhibiting a strong inhibitory effect on hCA-I and hCA-II. The compounds inhibit the enzymes by interacting out of catalytic active site. The sulfonamide and thiophene moiety played a significant role in the inhibition of the enzymes. Conclusion We hope that this study will contribute to the design of novel thiophene-based sulfonamide derived therapeutic agents that may be carbonic anhydrase inhibitors in inhibitor design studies.
BACKGROUNDThiophene(s) are an important group in therapeutic applications, and sulfonamides are the most important class of carbonic anhydrase (CA) inhibitors. In this study, inhibition effects of some thiophene-based sulfonamides on human erythrocytes carbonic anhydrase I and II isoenzymes (hCA-I and hCA-II) were investigated. Thiophene-based sulfonamides used in this study showed potent inhibition effect on both isoenzymes at very small concentrations. MATERIALS AND METHODSWe report on the purification of the carbonic anhydrase I and II isoenzymes (hCA-I and hCA-II) using affinity chromatography method. The inhibition effect of the thiophene-based sulfonamides was determined by IC50 and Ki parameters. A molecular docking study was performed for each molecule. RESULTSThiophene-based sulfonamides showed IC50 values of in the range of 69 nM to 70 µM against hCA-I, 23.4 nM to 1.405 µM against hCA-II. Ki values were in the range of 66.49 ± 17.15 nM to 234.99 ± 15.44 µM against hCA-I, 74.88 ± 20.65 nM to 38.04 ± 12.97 µM against hCA-II. Thiophene-based sulfonamides studied in this research showed noncompetitive inhibitory properties on both isoenzymes. To elucidate the mechanism of inhibition, a molecular docking study was performed for molecules 1 and 4 exhibiting a strong inhibitory effect on hCA-I and hCA-II. The compounds inhibit the enzymes by interacting out of catalytic active site. The sulfonamide and thiophene moiety played a significant role in the inhibition of the enzymes. CONCLUSIONWe hope that this study will contribute to the design of novel thiophene-based sulfonamide derived therapeutic agents that may be carbonic anhydrase inhibitors in inhibitor design studies.
Author Alım, Zuhal
Karaman, Muhammet
Köksal, Zeynep
Author_xml – sequence: 1
  givenname: Zuhal
  surname: Alım
  fullname: Alım, Zuhal
  organization: Department of Chemistry, Faculty of Science and Arts, Kırşehir Ahi Evran University
– sequence: 2
  givenname: Zeynep
  surname: Köksal
  fullname: Köksal, Zeynep
  email: zeynep.koksal@medeniyet.edu.tr
  organization: Department of Chemistry, Faculty of Engineering and Natural Sciences, Istanbul Medeniyet University
– sequence: 3
  givenname: Muhammet
  surname: Karaman
  fullname: Karaman, Muhammet
  organization: Department of Molecular Biology and Genetics, Faculty of Arts and Sciences, Kilis 7 Aralık University
BookMark eNp9kc1u1TAQhS1UJG4LL8DKSzYB_107WaKqwJUqsYG15diTxiWxLx4HKTwaT4fby5rFaM7ifEczOtfkKuUEhLzl7D1nzHxAJZViHRNtGFdDp16QgxDD0B11r67IgRupOs4Ve0WuER8ZU1zI44H8ufvlls3VmBPNE8W8Aq1zzOcZEnSjQwgUt2XKya0xAFKH9JwrpEpjmuMYay74RHpXxpyipy7NeygNpKemAz2daMQM6fe-NrzJxdUWOpW80nlbXaJQ9jqX7PfaDONOf8QE9Tkp0DUv4LfFlaYCLEtMDxTrFiLga_JycgvCm3_7hnz_dPft9kt3__Xz6fbjfeelULUT4zQqM-nAmRTc6HHoJ8_80agAik9aadM74bVmAvwwCO57wxyMRjN11DrIG_Luknsu-ecGWO0a0bdbXIK8oRVKMmkG1ffNKi5WXzJigcmeS1xd2S1n9qkoeynKtqLsc1FWNUheIGzm9ADFPuatpPbS_6i_O6-cxw
CitedBy_id crossref_primary_10_1002_slct_202204191
crossref_primary_10_1016_j_jfca_2023_105842
crossref_primary_10_1016_j_molstruc_2022_132630
crossref_primary_10_1016_j_eurpolymj_2024_112930
crossref_primary_10_1016_j_rechem_2023_101174
crossref_primary_10_1002_bdd_2309
crossref_primary_10_1016_j_molstruc_2021_130498
crossref_primary_10_1016_j_molstruc_2022_133647
crossref_primary_10_1134_S1068162022040124
crossref_primary_10_1002_aoc_6537
crossref_primary_10_1016_j_ijbiomac_2021_08_128
crossref_primary_10_2174_0929867329666220722143547
crossref_primary_10_17714_gumusfenbil_1359988
crossref_primary_10_1002_cbdv_202300207
Cites_doi 10.1517/13543776.2013.780598
10.1016/j.molstruc.2020.127868
10.3109/14756366.2015.1122001
10.1038/nature04710
10.1016/j.bioorg.2020.103762
10.1517/13543776.14.5.667
10.1038/227680a0
10.1016/j.bioorg.2018.12.012
10.1002/jbt.22421
10.1051/jbio:2007014
10.1021/cr200176r
10.1016/0003-2697(76)90527-3
10.1002/jbt.22300
10.2174/0929867033457647
10.1016/j.bmc.2015.02.027
10.4155/fmc.14.68
10.1517/13543776.2013.790957
10.1517/13543776.2013.798648
10.1111/cbdd.12561
10.1016/j.bmc.2007.04.020
10.1016/j.bioorg.2020.103839
10.1016/j.molstruc.2018.11.038
10.1002/ardp.201800359
10.1016/j.bioorg.2019.103468
10.1186/s13065-018-0511-5
10.1021/ja01318a036
10.1016/j.bioorg.2019.103213
10.3390/molecules22101642
10.1080/17460441.2017.1253677
10.1517/13543776.2013.778246
10.1002/jbt.22194
10.3109/14756366.2013.787422
10.1016/S0169-409X(00)00129-0
10.1039/C4CC07320G
10.1016/S0021-9258(18)95800-X
10.1016/S0021-9258(18)51011-5
ContentType Journal Article
Copyright Maj Institute of Pharmacology Polish Academy of Sciences 2020
Copyright_xml – notice: Maj Institute of Pharmacology Polish Academy of Sciences 2020
DBID AAYXX
CITATION
7X8
DOI 10.1007/s43440-020-00149-4
DatabaseName CrossRef
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
EISSN 2299-5684
EndPage 1748
ExternalDocumentID 10_1007_s43440_020_00149_4
GroupedDBID ---
--M
123
29O
2WC
3EA
4.4
406
457
53G
7-5
8P~
AACTN
AAEDT
AAFGU
AAHNG
AAIKJ
AAKOC
AALRI
AAOAW
AATNV
AAUYE
AAXLA
AAXUO
AAYFA
ABECU
ABFRF
ABJNI
ABKAS
ABMQK
ABMZM
ABTEG
ABTKH
ABXDB
ABYKQ
ACDAQ
ACGFO
ACGFS
ACHSB
ACIGE
ACTTH
ACVWB
ACWMK
ADBBV
ADEZE
ADOXG
ADTPH
ADYFF
AEFTE
AEFWE
AEKER
AENEX
AESKC
AESTI
AFNRJ
AFQWF
AFTJW
AGHFR
AGMZJ
AGUBO
AILAN
AITUG
AJBFU
AJDOV
AJOXV
AJZVZ
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMTXH
AMXSW
AMYLF
ANZVX
BAWUL
BGNMA
BLXMC
DIK
DPUIP
E3Z
EBLON
EBS
EJD
F5P
FDB
FEDTE
FIRID
FNLPD
GBLVA
GX1
HH5
HVGLF
IKXTQ
IWAJR
JZLTJ
KOV
LLZTM
M4Y
M~E
NPVJJ
NQJWS
NU0
OAUVE
PT4
RNS
ROL
RSV
SNE
SNPRN
SOHCF
SOJ
SRMVM
SSLCW
SSZ
T5K
TR2
UNMZH
XSB
Y2W
ZMTXR
~G-
0R~
AACDK
AAJBT
AASML
AAYXX
ABAKF
ACAOD
ACDTI
ACZOJ
AEFQL
AEMSY
AFBBN
AGQEE
AIGIU
CITATION
FIGPU
SJYHP
7X8
ID FETCH-LOGICAL-c324t-2bfb47f6d1032176b98fc0c574de41f64678a2c6602ec9921c870aeb7604566d3
ISSN 1734-1140
IngestDate Fri Oct 25 08:39:00 EDT 2024
Thu Sep 12 19:42:51 EDT 2024
Sat Dec 16 12:01:24 EST 2023
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Sulfonamide
Molecular modelling
Thiophene
Inhibition
Carbonic anhydrase
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c324t-2bfb47f6d1032176b98fc0c574de41f64678a2c6602ec9921c870aeb7604566d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PQID 2430379488
PQPubID 23479
PageCount 11
ParticipantIDs proquest_miscellaneous_2430379488
crossref_primary_10_1007_s43440_020_00149_4
springer_journals_10_1007_s43440_020_00149_4
PublicationCentury 2000
PublicationDate 2020-12-01
PublicationDateYYYYMMDD 2020-12-01
PublicationDate_xml – month: 12
  year: 2020
  text: 2020-12-01
  day: 01
PublicationDecade 2020
PublicationPlace Cham
PublicationPlace_xml – name: Cham
PublicationTitle Pharmacological reports
PublicationTitleAbbrev Pharmacol. Rep
PublicationYear 2020
Publisher Springer International Publishing
Publisher_xml – name: Springer International Publishing
References Alım (CR16) 2018; 32
Sanguinetti, Tristani-Firouzi (CR34) 2006; 440
Carta, Supuran (CR8) 2013; 23
Wilbur, Anderson (CR18) 1948; 176
Bradford (CR19) 1976; 72
Supuran (CR41) 2016; 31
Supuran, Scozzafava (CR14) 2007; 15
Taslimi, Turkan, Çetin, Burhan, Karaman, Bildirici (CR29) 2019; 92
Karimov, Orujova, Taslimi, Sadeghian, Mammadov, Karaman (CR37) 2020; 99
Koksal, Alım, Bayrak, Gulcin, Ozdemir (CR17) 2019; 33
CR30
Capasso, Supuran (CR3) 2014; 29
Lineweaver, Burk (CR22) 1934; 56
Burmaoglu, Akin-Kazancioglu, Kaya, Kazancioglu, Karaman, Algul (CR39) 2020; 1208
Lipinski, Lombardo, Dominy, Feeney (CR36) 2001; 46
Alım, Kilinc, Sengul, Beydemir (CR15) 2015; 86
Laemmli (CR20) 1970; 227
Scozzafava, Owa, Mastrolorenzo, Supuran (CR4) 2003; 10
Shah, Verma (CR35) 2018; 12
(CR33) 2019
Turkan, Cetin, Taslimi, Karaman, Gulcin (CR32) 2019; 352
Monti, Supuran, De Simone (CR5) 2013; 23
Loubatières-Mariani (CR7) 2007; 201
Alterio, Di Fiore, D’Ambrosio, Supuran, De Simone (CR11) 2012; 112
Supuran (CR12) 2013; 23
Carta, Di Cesare, Pinard, Ghelardini, Scozzafava, McKenna, Supuran (CR9) 2015; 23
Verpoorte, Mehta, Edsall (CR21) 1967; 242
CR28
CR26
Bal, Kaya, Gök, Taslimi, Aktaş, Karaman (CR27) 2020; 94
CR23
Kalin, Koksal, Kalin, Karaman, Gulcin, Ozdemir (CR24) 2020; 34
Scozzafava, Mastrolorenzo, Supuran (CR13) 2004; 14
Yigit, Kaya, Taslimi, Isık, Karaman, Yigit (CR31) 2019; 1179
Carta, Supuran, Scozzafava (CR10) 2014; 6
Supuran (CR1) 2017; 12
D’Ambrosio, Carradori, Monti, Buonanno, Secci, Vullo (CR40) 2015; 51
Supuran (CR2) 2017; 22
Scozzafava, Supuran, Carta (CR6) 2013; 23
Bayrak, Taslimi, Karaman, Gulcin, Menzek (CR25) 2019; 85
Singh, Swain, Thacker, Sigalapalli, Yadav, Angeli (CR38) 2020; 99
Z Koksal (149_CR17) 2019; 33
K D’Ambrosio (149_CR40) 2015; 51
F Carta (149_CR9) 2015; 23
149_CR30
Induced Fit Docking protocol; Glide (149_CR33) 2019
MC Sanguinetti (149_CR34) 2006; 440
A Scozzafava (149_CR13) 2004; 14
S Burmaoglu (149_CR39) 2020; 1208
F Carta (149_CR10) 2014; 6
CA Lipinski (149_CR36) 2001; 46
CT Supuran (149_CR12) 2013; 23
MM Bradford (149_CR19) 1976; 72
A Scozzafava (149_CR6) 2013; 23
F Turkan (149_CR32) 2019; 352
F Carta (149_CR8) 2013; 23
P Taslimi (149_CR29) 2019; 92
A Scozzafava (149_CR4) 2003; 10
S Bal (149_CR27) 2020; 94
R Shah (149_CR35) 2018; 12
149_CR26
A Karimov (149_CR37) 2020; 99
CT Supuran (149_CR2) 2017; 22
H Lineweaver (149_CR22) 1934; 56
149_CR28
MM Loubatières-Mariani (149_CR7) 2007; 201
149_CR23
B Yigit (149_CR31) 2019; 1179
R Kalin (149_CR24) 2020; 34
C Bayrak (149_CR25) 2019; 85
CT Supuran (149_CR1) 2017; 12
SM Monti (149_CR5) 2013; 23
V Alterio (149_CR11) 2012; 112
UK Laemmli (149_CR20) 1970; 227
CT Supuran (149_CR41) 2016; 31
JA Verpoorte (149_CR21) 1967; 242
C Capasso (149_CR3) 2014; 29
CT Supuran (149_CR14) 2007; 15
Z Alım (149_CR15) 2015; 86
KM Wilbur (149_CR18) 1948; 176
P Singh (149_CR38) 2020; 99
Z Alım (149_CR16) 2018; 32
References_xml – volume: 23
  start-page: 681
  year: 2013
  end-page: 691
  ident: CR8
  article-title: Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005–2013)
  publication-title: Expert Opin Ther Pat
  doi: 10.1517/13543776.2013.780598
  contributor:
    fullname: Supuran
– volume: 1208
  start-page: 127868
  year: 2020
  ident: CR39
  article-title: Synthesis of novel organohalogen chalcone derivatives and screening of their molecular docking study and some enzymes inhibition effects
  publication-title: J Mol Struct
  doi: 10.1016/j.molstruc.2020.127868
  contributor:
    fullname: Algul
– volume: 31
  start-page: 345
  year: 2016
  end-page: 360
  ident: CR41
  article-title: How many carbonic anhydrase inhibition mechanisms exist?
  publication-title: J Enzyme Inhib Med Chem
  doi: 10.3109/14756366.2015.1122001
  contributor:
    fullname: Supuran
– volume: 242
  start-page: 4221
  year: 1967
  end-page: 4229
  ident: CR21
  article-title: Esterase activities of human carbonic anhydrases B and C
  publication-title: J Biol Chem
  contributor:
    fullname: Edsall
– volume: 440
  start-page: 463
  year: 2006
  end-page: 469
  ident: CR34
  article-title: hERG potassium channels and cardiac arrhythmia
  publication-title: Nature
  doi: 10.1038/nature04710
  contributor:
    fullname: Tristani-Firouzi
– ident: CR30
– volume: 99
  start-page: 103762
  year: 2020
  ident: CR37
  article-title: Novel functionally substituted esters based on sodium diethyldithiocarbamate derivatives: synthesis, characterization, biological activity and molecular docking studies
  publication-title: Bioorg Chem
  doi: 10.1016/j.bioorg.2020.103762
  contributor:
    fullname: Karaman
– volume: 14
  start-page: 667
  year: 2004
  end-page: 702
  ident: CR13
  article-title: Modulation of carbonic anhydrase activity and its applications in therapy
  publication-title: Expert Opın Ther Pat.
  doi: 10.1517/13543776.14.5.667
  contributor:
    fullname: Supuran
– volume: 227
  start-page: 680
  year: 1970
  end-page: 685
  ident: CR20
  article-title: Cleavage of structural proteins during the assembly of the head of bacteriophage T4
  publication-title: Nature
  doi: 10.1038/227680a0
  contributor:
    fullname: Laemmli
– volume: 85
  start-page: 128
  year: 2019
  end-page: 139
  ident: CR25
  article-title: The first synthesis, carbonic anhydrase inhibition and anticholinergic activities of some bromophenol derivatives with S including natural products
  publication-title: Bioorg Chem
  doi: 10.1016/j.bioorg.2018.12.012
  contributor:
    fullname: Menzek
– volume: 34
  start-page: e22421
  year: 2020
  ident: CR24
  article-title: In vitro effects of standard antioxidants on lactoperoxidase enzyme—a molecular docking approach
  publication-title: J Biochem Mol Toxicol
  doi: 10.1002/jbt.22421
  contributor:
    fullname: Ozdemir
– volume: 201
  start-page: 121
  year: 2007
  end-page: 125
  ident: CR7
  article-title: The discovery of hypoglycemic sulfonamides
  publication-title: J Soc Biol
  doi: 10.1051/jbio:2007014
  contributor:
    fullname: Loubatières-Mariani
– volume: 112
  start-page: 4421
  year: 2012
  end-page: 4468
  ident: CR11
  article-title: Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?
  publication-title: Chem Rev
  doi: 10.1021/cr200176r
  contributor:
    fullname: De Simone
– volume: 72
  start-page: 248
  year: 1976
  end-page: 254
  ident: CR19
  article-title: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding
  publication-title: Anal Biochem
  doi: 10.1016/0003-2697(76)90527-3
  contributor:
    fullname: Bradford
– volume: 33
  start-page: e22300
  issue: 5
  year: 2019
  ident: CR17
  article-title: Investigation of the effects of some sulfonamides on acetylcholinesterase and carbonic anhydrase enzymes
  publication-title: J Biochem Mol Toxicol
  doi: 10.1002/jbt.22300
  contributor:
    fullname: Ozdemir
– volume: 10
  start-page: 925
  year: 2003
  end-page: 953
  ident: CR4
  article-title: Anticancer and antiviral sulfonamides
  publication-title: Curr Med Chem
  doi: 10.2174/0929867033457647
  contributor:
    fullname: Supuran
– volume: 23
  start-page: 1828
  year: 2015
  end-page: 1840
  ident: CR9
  article-title: A class of sulfonamide carbonic anhydrase inhibitors with neuropathic pain modulating effects
  publication-title: Bioorg Med Chem
  doi: 10.1016/j.bmc.2015.02.027
  contributor:
    fullname: Supuran
– volume: 6
  start-page: 1149
  year: 2014
  end-page: 1165
  ident: CR10
  article-title: Sulfonamides and their isosters as carbonic anhydrase inhibitors
  publication-title: Future Med. Chem.
  doi: 10.4155/fmc.14.68
  contributor:
    fullname: Scozzafava
– volume: 23
  start-page: 725
  year: 2013
  end-page: 735
  ident: CR6
  article-title: Antiobesity carbonic anhydrase inhibitors: a literature and patent review
  publication-title: Expert Opin Ther Pat
  doi: 10.1517/13543776.2013.790957
  contributor:
    fullname: Carta
– ident: CR23
– volume: 23
  start-page: 737
  year: 2013
  end-page: 749
  ident: CR5
  article-title: Anticancer carbonic anhydrase inhibitors: a patent review (2008–2013)
  publication-title: Expert Opin Ther Pat
  doi: 10.1517/13543776.2013.798648
  contributor:
    fullname: De Simone
– volume: 86
  start-page: 857
  year: 2015
  end-page: 863
  ident: CR15
  article-title: Some anti-ınflammatory agents ınhibit esterase activities of human carbonic anhydrase ısoforms i and II: an in vitro study
  publication-title: Chem Biol Drug Des
  doi: 10.1111/cbdd.12561
  contributor:
    fullname: Beydemir
– volume: 15
  start-page: 4336
  year: 2007
  end-page: 4350
  ident: CR14
  article-title: Carbonic anhydrases as targets for medicinal chemistry
  publication-title: Bioorg Med Chem
  doi: 10.1016/j.bmc.2007.04.020
  contributor:
    fullname: Scozzafava
– volume: 176
  start-page: 147
  year: 1948
  end-page: 154
  ident: CR18
  article-title: Electrometric and colorimetric determination of carbonic anhydrase
  publication-title: J Biol Chem
  contributor:
    fullname: Anderson
– volume: 99
  start-page: 103839
  year: 2020
  ident: CR38
  article-title: Synthesis and carbonic anhydrase inhibition studies of sulfonamide based indole-1,2,3-triazole chalcone hybrids
  publication-title: Bioorg Chem
  doi: 10.1016/j.bioorg.2020.103839
  contributor:
    fullname: Angeli
– volume: 1179
  start-page: 709
  year: 2019
  end-page: 718
  ident: CR31
  article-title: Imidazolinium chloride salts bearing wingtip groups: synthesis, molecular docking and metabolic enzymes inhibition
  publication-title: J Mol Struct
  doi: 10.1016/j.molstruc.2018.11.038
  contributor:
    fullname: Yigit
– volume: 352
  start-page: e1800359
  year: 2019
  ident: CR32
  article-title: Synthesis, characterization, molecular docking and biological activities of novel pyrazoline derivatives
  publication-title: Arch Pharm
  doi: 10.1002/ardp.201800359
  contributor:
    fullname: Gulcin
– volume: 94
  start-page: 103468
  year: 2020
  ident: CR27
  article-title: Novel 2-methylimidazolium salts: synthesis, characterization, molecular docking, and carbonic anhydrase and acetylcholinesterase inhibitory properties
  publication-title: Bioorg Chem
  doi: 10.1016/j.bioorg.2019.103468
  contributor:
    fullname: Karaman
– volume: 12
  start-page: 137
  year: 2018
  ident: CR35
  article-title: Therapeutic importance of synthetic thiophene
  publication-title: Chem Cent J
  doi: 10.1186/s13065-018-0511-5
  contributor:
    fullname: Verma
– volume: 56
  start-page: 658
  year: 1934
  end-page: 666
  ident: CR22
  article-title: The determination of enzyme dissociation constants
  publication-title: J Am Chem Soc
  doi: 10.1021/ja01318a036
  contributor:
    fullname: Burk
– volume: 92
  start-page: 103213
  year: 2019
  ident: CR29
  article-title: Pyrazole[3,4-d]pyridazine derivatives: molecular docking and explore of acetylcholinesterase and carbonic anhydrase enzymes inhibitors as anticholinergics potentials
  publication-title: Bioorg Chem
  doi: 10.1016/j.bioorg.2019.103213
  contributor:
    fullname: Bildirici
– year: 2019
  ident: CR33
  publication-title: Schrödinger, LLC, New York, NY, 2016
– volume: 22
  start-page: 1642
  year: 2017
  ident: CR2
  article-title: Special ıssue: sulfonamides
  publication-title: Molecules
  doi: 10.3390/molecules22101642
  contributor:
    fullname: Supuran
– volume: 12
  start-page: 61
  year: 2017
  end-page: 88
  ident: CR1
  article-title: Advances in structure-based drug discovery of carbonic anhydrase inhibitors
  publication-title: Expert Opin Drug Discov
  doi: 10.1080/17460441.2017.1253677
  contributor:
    fullname: Supuran
– volume: 23
  start-page: 677
  year: 2013
  end-page: 679
  ident: CR12
  article-title: Carbonic anhydrase inhibitors: an editorial
  publication-title: Expert Opin Ther Pat
  doi: 10.1517/13543776.2013.778246
  contributor:
    fullname: Supuran
– volume: 32
  start-page: e22194
  year: 2018
  ident: CR16
  article-title: 1H-indazole molecules reduced the activity of human erythrocytes carbonic anhydrase I and II isoenzymes
  publication-title: J Biochem Mol Toxicol
  doi: 10.1002/jbt.22194
  contributor:
    fullname: Alım
– volume: 29
  start-page: 379
  year: 2014
  end-page: 387
  ident: CR3
  article-title: Sulfa and trimethoprim-like drugs-antimetabolites acting as carbonic anhydrase, dihydropteroate synthase and dihydrofolate reductase inhibitors
  publication-title: J Enzyme Inhib Med Chem
  doi: 10.3109/14756366.2013.787422
  contributor:
    fullname: Supuran
– ident: CR28
– volume: 46
  start-page: 3
  year: 2001
  end-page: 26
  ident: CR36
  article-title: Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
  publication-title: Adv Drug Deliv Rev
  doi: 10.1016/S0169-409X(00)00129-0
  contributor:
    fullname: Feeney
– ident: CR26
– volume: 51
  start-page: 302
  year: 2015
  end-page: 305
  ident: CR40
  article-title: Out of the active site binding pocket for carbonic anhydrase inhibitors
  publication-title: Chem Commun
  doi: 10.1039/C4CC07320G
  contributor:
    fullname: Vullo
– volume: 201
  start-page: 121
  year: 2007
  ident: 149_CR7
  publication-title: J Soc Biol
  doi: 10.1051/jbio:2007014
  contributor:
    fullname: MM Loubatières-Mariani
– volume: 352
  start-page: e1800359
  year: 2019
  ident: 149_CR32
  publication-title: Arch Pharm
  doi: 10.1002/ardp.201800359
  contributor:
    fullname: F Turkan
– volume: 12
  start-page: 137
  year: 2018
  ident: 149_CR35
  publication-title: Chem Cent J
  doi: 10.1186/s13065-018-0511-5
  contributor:
    fullname: R Shah
– ident: 149_CR26
– volume-title: Schrödinger, LLC, New York, NY, 2016
  year: 2019
  ident: 149_CR33
  contributor:
    fullname: Induced Fit Docking protocol; Glide
– volume: 94
  start-page: 103468
  year: 2020
  ident: 149_CR27
  publication-title: Bioorg Chem
  doi: 10.1016/j.bioorg.2019.103468
  contributor:
    fullname: S Bal
– ident: 149_CR30
– volume: 23
  start-page: 737
  year: 2013
  ident: 149_CR5
  publication-title: Expert Opin Ther Pat
  doi: 10.1517/13543776.2013.798648
  contributor:
    fullname: SM Monti
– volume: 23
  start-page: 725
  year: 2013
  ident: 149_CR6
  publication-title: Expert Opin Ther Pat
  doi: 10.1517/13543776.2013.790957
  contributor:
    fullname: A Scozzafava
– volume: 10
  start-page: 925
  year: 2003
  ident: 149_CR4
  publication-title: Curr Med Chem
  doi: 10.2174/0929867033457647
  contributor:
    fullname: A Scozzafava
– volume: 31
  start-page: 345
  year: 2016
  ident: 149_CR41
  publication-title: J Enzyme Inhib Med Chem
  doi: 10.3109/14756366.2015.1122001
  contributor:
    fullname: CT Supuran
– volume: 32
  start-page: e22194
  year: 2018
  ident: 149_CR16
  publication-title: J Biochem Mol Toxicol
  doi: 10.1002/jbt.22194
  contributor:
    fullname: Z Alım
– volume: 1179
  start-page: 709
  year: 2019
  ident: 149_CR31
  publication-title: J Mol Struct
  doi: 10.1016/j.molstruc.2018.11.038
  contributor:
    fullname: B Yigit
– volume: 99
  start-page: 103839
  year: 2020
  ident: 149_CR38
  publication-title: Bioorg Chem
  doi: 10.1016/j.bioorg.2020.103839
  contributor:
    fullname: P Singh
– volume: 440
  start-page: 463
  year: 2006
  ident: 149_CR34
  publication-title: Nature
  doi: 10.1038/nature04710
  contributor:
    fullname: MC Sanguinetti
– volume: 46
  start-page: 3
  year: 2001
  ident: 149_CR36
  publication-title: Adv Drug Deliv Rev
  doi: 10.1016/S0169-409X(00)00129-0
  contributor:
    fullname: CA Lipinski
– volume: 34
  start-page: e22421
  year: 2020
  ident: 149_CR24
  publication-title: J Biochem Mol Toxicol
  doi: 10.1002/jbt.22421
  contributor:
    fullname: R Kalin
– volume: 1208
  start-page: 127868
  year: 2020
  ident: 149_CR39
  publication-title: J Mol Struct
  doi: 10.1016/j.molstruc.2020.127868
  contributor:
    fullname: S Burmaoglu
– volume: 23
  start-page: 677
  year: 2013
  ident: 149_CR12
  publication-title: Expert Opin Ther Pat
  doi: 10.1517/13543776.2013.778246
  contributor:
    fullname: CT Supuran
– volume: 15
  start-page: 4336
  year: 2007
  ident: 149_CR14
  publication-title: Bioorg Med Chem
  doi: 10.1016/j.bmc.2007.04.020
  contributor:
    fullname: CT Supuran
– volume: 12
  start-page: 61
  year: 2017
  ident: 149_CR1
  publication-title: Expert Opin Drug Discov
  doi: 10.1080/17460441.2017.1253677
  contributor:
    fullname: CT Supuran
– volume: 29
  start-page: 379
  year: 2014
  ident: 149_CR3
  publication-title: J Enzyme Inhib Med Chem
  doi: 10.3109/14756366.2013.787422
  contributor:
    fullname: C Capasso
– ident: 149_CR28
– volume: 22
  start-page: 1642
  year: 2017
  ident: 149_CR2
  publication-title: Molecules
  doi: 10.3390/molecules22101642
  contributor:
    fullname: CT Supuran
– volume: 23
  start-page: 1828
  year: 2015
  ident: 149_CR9
  publication-title: Bioorg Med Chem
  doi: 10.1016/j.bmc.2015.02.027
  contributor:
    fullname: F Carta
– volume: 86
  start-page: 857
  year: 2015
  ident: 149_CR15
  publication-title: Chem Biol Drug Des
  doi: 10.1111/cbdd.12561
  contributor:
    fullname: Z Alım
– volume: 85
  start-page: 128
  year: 2019
  ident: 149_CR25
  publication-title: Bioorg Chem
  doi: 10.1016/j.bioorg.2018.12.012
  contributor:
    fullname: C Bayrak
– volume: 72
  start-page: 248
  year: 1976
  ident: 149_CR19
  publication-title: Anal Biochem
  doi: 10.1016/0003-2697(76)90527-3
  contributor:
    fullname: MM Bradford
– volume: 227
  start-page: 680
  year: 1970
  ident: 149_CR20
  publication-title: Nature
  doi: 10.1038/227680a0
  contributor:
    fullname: UK Laemmli
– volume: 99
  start-page: 103762
  year: 2020
  ident: 149_CR37
  publication-title: Bioorg Chem
  doi: 10.1016/j.bioorg.2020.103762
  contributor:
    fullname: A Karimov
– volume: 92
  start-page: 103213
  year: 2019
  ident: 149_CR29
  publication-title: Bioorg Chem
  doi: 10.1016/j.bioorg.2019.103213
  contributor:
    fullname: P Taslimi
– volume: 33
  start-page: e22300
  issue: 5
  year: 2019
  ident: 149_CR17
  publication-title: J Biochem Mol Toxicol
  doi: 10.1002/jbt.22300
  contributor:
    fullname: Z Koksal
– volume: 14
  start-page: 667
  year: 2004
  ident: 149_CR13
  publication-title: Expert Opın Ther Pat.
  doi: 10.1517/13543776.14.5.667
  contributor:
    fullname: A Scozzafava
– volume: 242
  start-page: 4221
  year: 1967
  ident: 149_CR21
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(18)95800-X
  contributor:
    fullname: JA Verpoorte
– volume: 112
  start-page: 4421
  year: 2012
  ident: 149_CR11
  publication-title: Chem Rev
  doi: 10.1021/cr200176r
  contributor:
    fullname: V Alterio
– volume: 6
  start-page: 1149
  year: 2014
  ident: 149_CR10
  publication-title: Future Med. Chem.
  doi: 10.4155/fmc.14.68
  contributor:
    fullname: F Carta
– volume: 56
  start-page: 658
  year: 1934
  ident: 149_CR22
  publication-title: J Am Chem Soc
  doi: 10.1021/ja01318a036
  contributor:
    fullname: H Lineweaver
– volume: 23
  start-page: 681
  year: 2013
  ident: 149_CR8
  publication-title: Expert Opin Ther Pat
  doi: 10.1517/13543776.2013.780598
  contributor:
    fullname: F Carta
– ident: 149_CR23
– volume: 51
  start-page: 302
  year: 2015
  ident: 149_CR40
  publication-title: Chem Commun
  doi: 10.1039/C4CC07320G
  contributor:
    fullname: K D’Ambrosio
– volume: 176
  start-page: 147
  year: 1948
  ident: 149_CR18
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(18)51011-5
  contributor:
    fullname: KM Wilbur
SSID ssj0041235
Score 2.4247854
Snippet Background Thiophene(s) are an important group in therapeutic applications, and sulfonamides are the most important class of carbonic anhydrase (CA)...
BACKGROUNDThiophene(s) are an important group in therapeutic applications, and sulfonamides are the most important class of carbonic anhydrase (CA) inhibitors....
SourceID proquest
crossref
springer
SourceType Aggregation Database
Publisher
StartPage 1738
SubjectTerms Drug Safety and Pharmacovigilance
Medicine
Pharmacotherapy
Pharmacy
Title Evaluation of some thiophene-based sulfonamides as potent inhibitors of carbonic anhydrase I and II isoenzymes isolated from human erythrocytes by kinetic and molecular modelling studies
URI https://link.springer.com/article/10.1007/s43440-020-00149-4
https://search.proquest.com/docview/2430379488
Volume 72
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtpAFB3RZNNN1adK-tCtVGUDrsAMY3sZKlBoU9oFSCgba2yPBUqwEYaF80X9hn5d7x2PH0mjKu3GGtnMGOkc38fMfTD2Meh5YTh0lCWcwEYHZehaMhL4uQceVaJ1hBfqap8zcb7gX5bDZav1sxG1dNgHn8Kbe_NK_gdVvIe4UpbsPyBbLYo3cIz44hURxuuDMB5XpbrJ5svSjUI7ck2VAhJlkX6KKPo8TqnpfKQy6imzTfd0-r9OVutgrTvtUFy53AW6E45MVnm0w4mdaREoPO2ss1QlNznVdMLhtSQLVeekFN391C6nTgthTvu3aMpeodVa1oDdlK13i34718XWRR23aGziH3X1bM0Yc4xRUVGbv6O-Ju7lYSWrmJCvdMo_EleZblrQuVR5orbVQ7mTZnf3G07abEymt9nhsJvRIoVQdgbcQr-t15Tajt1gZ1ME46_dhjpHj8u9V1UU0SEZH9DpNr1Ve4sm5ehWXe7Zd3-yuLjw5-Pl_BE7tlGkoSw9PpuMRrNS63PKOdbJt-a_mgQtnab5xztuG0G1Z3PnMF7bOPOn7IlxTuCsYNoz1lLJc3Zq8Mm7MK-T9bIunEIDufwF-1XTEdIYiI5wh47QpCPIDAo6Qk1HmlnSESo6whTHEUynUNMRSjoC0RE0HaFJRwhyMHTUsys6QkVHMHR8yRaT8fzzuWVag1ghegB7yw7igDuxiKgeZN8RgefGYQ-FDo8U78cC1b8r7VCInq1Cz7P7IeolqQJHkAsjosErdpSkiXrNIOL4UAhvGPVjLmLlxo5CvSddbnMle6rNOiVW_raoAONXtb41sj4i62tkfd5mH0o4fRTUdPomE5UeMt_maC2i9nPdNuuWOPtGmmR_WfLkAUu-YY_rL-ctO9rvDuodWsv74L0h6m8y5sf7
link.rule.ids 315,783,787,27936,27937
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+of+some+thiophene-based+sulfonamides+as+potent+inhibitors+of+carbonic+anhydrase+I+and+II+isoenzymes+isolated+from+human+erythrocytes+by+kinetic+and+molecular+modelling+studies&rft.jtitle=Pharmacological+reports&rft.au=Al%C4%B1m%2C+Zuhal&rft.au=K%C3%B6ksal%2C+Zeynep&rft.au=Karaman%2C+Muhammet&rft.date=2020-12-01&rft.issn=1734-1140&rft.volume=72&rft.issue=6&rft.spage=1738&rft.epage=1748&rft_id=info:doi/10.1007%2Fs43440-020-00149-4&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1734-1140&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1734-1140&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1734-1140&client=summon